This program originally aired on March 5, 2025. Please note that this program recording is not eligible for CLE/CPD credit.

The patent misuse doctrine can be a formidable defense for licensees in raising claims that could result in the unenforceability of patents. This presentation will explore the doctrine and related licensing issues that arise when negotiating IP license agreements in the life sciences before and after the licensed patents expire. Panelists will discuss best practices for avoiding patent misuse and antitrust issues when licensing intellectual property, while fostering innovation.

Presented by:

Ilan Feuchtwang
General Counsel
Synthego Corporation  

Victoria Kruse
Director of Corporate Transactions
Caribou Biosciences

Jeffrey Smyth
Partner
Finnegan

Brian Kacedon
Partner
Finnegan

This program recording is not eligible for CLE/CPD.